Privia Health Group (NASDAQ:PRVA) Given New $30.00 Price Target at Needham & Company LLC

Privia Health Group (NASDAQ:PRVA) had its price objective lifted by Needham & Company LLC from $25.00 to $30.00 in a report released on Friday morning,Benzinga reports. They currently have a buy rating on the stock.

A number of other research firms also recently issued reports on PRVA. Stephens reissued an “overweight” rating and set a $26.00 price target on shares of Privia Health Group in a research report on Thursday, January 2nd. JPMorgan Chase & Co. boosted their price target on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Friday, November 29th. Barclays boosted their price target on Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research report on Friday, November 8th. JMP Securities reissued a “market outperform” rating and set a $26.00 price target on shares of Privia Health Group in a research report on Friday, February 14th. Finally, Truist Financial boosted their price objective on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. One research analyst has rated the stock with a hold rating, fifteen have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $26.59.

Privia Health Group Trading Down 1.9 %

PRVA stock opened at $24.97 on Friday. The stock has a 50-day moving average price of $22.40 and a two-hundred day moving average price of $20.59. Privia Health Group has a 12-month low of $15.92 and a 12-month high of $26.04. The company has a market cap of $3.00 billion, a PE ratio of 249.72, a price-to-earnings-growth ratio of 3.47 and a beta of 0.87.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. FMR LLC lifted its stake in shares of Privia Health Group by 1.5% in the third quarter. FMR LLC now owns 18,169,043 shares of the company’s stock worth $330,858,000 after acquiring an additional 271,645 shares in the last quarter. Durable Capital Partners LP lifted its stake in shares of Privia Health Group by 3.4% in the fourth quarter. Durable Capital Partners LP now owns 11,487,843 shares of the company’s stock worth $224,587,000 after acquiring an additional 378,255 shares in the last quarter. Riverbridge Partners LLC increased its holdings in Privia Health Group by 19.7% in the fourth quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company’s stock valued at $113,868,000 after buying an additional 958,418 shares during the last quarter. Geode Capital Management LLC increased its holdings in Privia Health Group by 1.0% in the third quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company’s stock valued at $43,986,000 after buying an additional 23,178 shares during the last quarter. Finally, Nuveen Asset Management LLC increased its holdings in Privia Health Group by 19.8% in the fourth quarter. Nuveen Asset Management LLC now owns 1,488,979 shares of the company’s stock valued at $29,110,000 after buying an additional 246,393 shares during the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.